AIGH Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

AIGH Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-43,601	Closed	-$345K	–	63
2022 Q3	$345K	Sell	43,601 -7,778	-15%	-$129K	0.14%	43
2022 Q2	$1.08M	Hold	51,379	–	–	0.45%	35
2022 Q1	$1.93M	Buy	51,379 +1,365	+3%	+$47.2K	0.7%	27
2021 Q4	$2.81M	Buy	+50,014	New	+$3.36M	0.88%	28

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return